The trademark application WIFI-BODY was filed by BioCopy AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on October 29, 2025, and still open for oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals, medical and veterinary preparations
Chemical preparations for use in DNA analysis [medical]
Reagents for use in analysis [for veterinary purposes]
Reagents for analytical purposes [for medical purposes]
Reagents for analytical purposes [for veterinary purposes]
Reagents for use in analysis [for medical purposes]
Reagents for use with analyzers [for veterinary purposes]
Reagents for use with analyzers [for medical purposes]
Vaccines
Diagnostic biomarker reagents for medical purposes.
The mark was filed in class 9 with following description of goods:
Apparatus for scientific research and laboratories
Measuring, detecting and monitoring instruments, indicators and controllers
DNA chips
DNA microarray
Microarray slides
Microscope slides
Biochips
Biosensors
Bioinformatics software.
The mark was filed in class 42 with following description of goods:
Science and technology services
Testing, authentication and quality control
Provision of information and data relating to medical and veterinary research and development
Providing information about industrial analysis and research services
Biochemical analysis
Biochemical research and analysis
Biological analysis
Biological research and analysis
Blood analysis services for scientific research purposes
Analytical laboratory services
Research and development of vaccines and medicines
Research and development services in the field of antibody technology
Research and development services relating to vaccines
Research and development services in the field of antibodies
Information technology services for the pharmaceutical and healthcare industries
Laboratory services relating to the production of monoclonal antibodies